REDWOOD CITY, Calif., Nov. 7, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today reported financial results for the three and nine months ended September 30, 2016.
Third Quarter Highlights:
Achieved revenue of $60.9 million in the third quarter of 2016, an increase of 296% as reported, over the same period of the prior year
U.S. revenue of $47.2 million for the third quarter of 2016
International revenue of $13.7 million in the third quarter of 2016 increased 27% in constant currency and 26% on an as-reported basis, both over the same period of the prior year
